Liver Cancer Trial, Recruiting NCT07280143 Sponsor: University of Bern Condition: Liver Cancer
Back to Liver Cancer

Liver Cancer Trial, Recruiting

NCT07280143
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You must be willing and able to sign a consent form to take part in the study
  • You must be 18 years old or older
  • You must have been diagnosed with breast cancer or colorectal cancer at least 5 years ago, but no more than 10 years ago, with no return of cancer or new cancer diagnosis during that time (minor skin cancers, certain early-stage bladder cancers, or very early non-spreading cancers are exceptions to this rule)
  • You may still be receiving or have previously received follow-up cancer treatment (adjuvant therapy) after your original diagnosis and still be eligible

Who may not be able to join:

  • You may not be able to join if you have a known or suspected long-term liver condition
  • You may not be able to join if you are pregnant or think you might be pregnant
  • For a part of the study involving MRI scans: you may not be able to take part in that portion if you cannot have an MRI, for example if you have claustrophobia (fear of enclosed spaces), or if you have any metal implants or devices in or on your body such as a pacemaker, defibrillator, artificial heart valve, cochlear implant, metal clips, spinal or brain stimulators, metal fragments, metal in your eyes, or orthopaedic hardware — or piercings that cannot be removed (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Eva Segelov, Prof., Department of Clinical Research, University of Bern

Phone: +41 79 804 04 05

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University of Bern
Registry
ClinicalTrials.gov
Start date
14 November 2025
Est. completion
14 July 2027

Where this trial is recruiting

🇨🇭 Switzerland

Primary endpoints

High probability of fMASLD

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov